MDNews - Cleveland-Akron-Canton

November/December 2015

Issue link: http://viewer.e-digitaledition.com/i/589857

Contents of this Issue

Navigation

Page 22 of 43

2 0 1 5 N OV E M B E R / D E C E M B E R ■ M D N E W S . CO M ■ MD NEWS Cleveland/Akron/Canton | 2 3 IT IS STRESSFUL FOR a person to hear that they have an abnormal chest X-ray or CT scan. What to do with the solitary pulmonary nodule (SPN)? With more CT scans and better resolution, lesions are being seen now that could not be identified a decade ago. An SPN is defined as a single, small (less than 30mm), usually well-circumscribed density seen on a radiograph, surrounded by lung parenchyma. A mass is a lesion greater than 30mm. Even with risk factors for malignancy, the majority of SPNs are benign. It is the clinician's role to help the patient make informed decisions about the differential diagnosis, relative risks of imaging, tissue diagnosis and observation. While a major focus is on the malignant lesion, assessing the etiology of SPN as to its nonmalignant status (benign tumors, scars, inflammatory, infectious or vascular lesions) has implications for the patient. A pulmonary physician trained in the evaluation of these lesions can often aid in the management. Three significant advances in this area are worthy of discussion. First, for years several societies and organizations have standardized the approach to SPN — solid and semi-solid — defining the risk factors for malignancy. The Fleischner Society (fleischner.org/) and the National Comprehensive Cancer Network (nccn.org) have developed excellent resources. These complementary approaches help optimize yield efficiency with minimization of risk, including unnecessary radiation and invasive procedures. Second is the Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) . The decision summary by the Centers for Medicare & Medicaid Services has determined that the evidence is sufficient to add a lung cancer screening counseling and shared decision making visit, and for appropriately screened beneficiaries, annual screening for lung cancer with LDCT. Their eligibility criteria include age, symptoms, smoking history, counseling on smoking, adherence to screening, and willingness to undergo diagnosis and treatment. Commercial insurance carriers are gradually allowing this as a benefit. Until then, many regional hospitals have a deeply discounted program for those willing to pay out of pocket for a screening LDCT not yet covered by their insurance company. Third, new technologies have allowed more accurate tissue diagnosis with potentially less invasion. Transtracheal and transbronchial needle biopsies/aspirations have been established for over thirty years, but these "blind" aspirates had a lower yield. Endobronchial Ultrasound has allowed for direct visualization of lymph nodes, and with the assistance of onsite cytopathologists, lymph nodes are being successfully sampled throughout the mediastinum and hilum. Peripheral nodules and masses are excellent candidates for the invasive radiologist's CT directed needle biopsies, but lesions in the inner two third of the lung, especially with visible airways are now being reached with greater accuracy than ever before with the use of electromagnetic navigation bronchoscopies (ENB). Using specialized CT scan images and software, this has made ENB the GPS of bronchoscopy. The bronchoscope and instruments are now being guided to lesions beyond direct visualization. This has allowed biopsy and culture of these previously difficult to reach lesions, as well as staging of malignancies, and placement of fiducial markers for future stereotactic radiotherapy treatment options. On the horizon is microwave technology that is being developed for minimally invasive treatment options also delivered by interventional radiology and bronchoscopy. Dr. Charles Fuenning is a board-certified pulmonary and critical care physician — one of thirteen pulmonary, critical care and sleep providers in Unity Health Network, the largest independent physician group in Northeast Ohio — and a member of the Ohio Independent Collaborative, an association of independent physician groups in Ohio that have nearly 750,000 covered lives. He is affiliated with Western Reserve Hospital and Summa Health System in Akron, Ohio. ■ By Charles Fuenning, MD, FCCP IMAGES COURTESY OF WESTERN RESERVE HOSPITAL, CUYAHOGA FALLS OHIO "I Have a Nodule on My Lung X-ray" ++++++++++++++++++++++++++++++++++++++ ++ + ++ + ++++++++++++++++++++++++++++++++++++++ ❮ CLINICAL SECTION: LUNG CANCER

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Cleveland-Akron-Canton - November/December 2015